Loading data
ESLANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 10.25 m USD | 4.11 m USD | 10.45 m USD | — | — |
| Operating profit | -13.06 m USD | -7.31 m USD | -11.11 m USD | -1.57 m USD | -249.15 k USD |
| Profit before tax | -13.06 m USD | -7.31 m USD | -11.11 m USD | -915.46 k USD | -247.72 k USD |
| Income tax expense | 838 USD | 1.63 k USD | — | 80.65 k USD | 0 USD |
| Net income (reported basis) | -13.06 m USD | -7.31 m USD | -11.11 m USD | -996.1 k USD | -247.72 k USD |
| Basic earnings per share | -0.35 USD/share | -0.27 USD/share | -36.35 USD/share | — | — |
| Diluted earnings per share | -0.35 USD/share | -0.27 USD/share | -36.35 USD/share | — | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.